Table 2.
Antimicrobial activity of AgNPs synthesized by HX-YS and LPP-12Y against five pathogenic microorganisms.
| Pathogenic microorganism | Zone of Inhibition (mm) | ||||
|---|---|---|---|---|---|
| E. coil ATCC8099 | S. aureus ATCC6538 | B. subtilis ATCC6051 | M. albican ATCC10231 | P. aeruginosa | |
| PDA | – | – | – | – | – |
| Kanamycin | 10.83 ± 0.57 | 10.43 ± 1.55 | 15.05 ± 1.51 | 19.22 ± 0.31 | – |
| Ampicillin | 7.51 ± 0.10 | 7.92 ± 0.54 | 11.44 ± 0.80 | – | – |
| Sample HX-YS | 14.81 ± 1.31 | 14.61 ± 1.72 | 15.29 ± 0.88 | 18.52 ± 0.45 | 21.44 ± 1.49 |
| Sample LPP-12Y | 15.23 ± 4.08 | 15.04 ± 1.31 | 16.23 ± 1.39 | 17.83 ± 1.22 | 21.78 ± 0.51 |
* The zone of inhibition (ZOI) is recorded as the mean ± SD (n = 3). The diameter of the disks is 6 mm. “–” means no ZOI was observed.